Skip to content

Lymphocyte immunotherapy in patients with unexplained recurrent spontaneous abortion

Lymphocyte immunotherapy in patients with unexplained recurrent spontaneous abortion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033738
Enrollment
Unknown
Registered
2020-06-11
Start date
2014-01-01
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphocyte immunotherapy

Interventions

Sponsors

Wenzhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: A total of 100 patients confirmed in the obstetrics and gynecology laboratory of our hospital were included in the URSA case group. Case inclusion criteria: the patient had no history of successful pregnancy, miscarriage of >=2 fetuses occurred before 28 weeks of gestation, and the male had normal chromosome karyotype in peripheral blood, and no abnormalities in semen examination.

Exclusion criteria

Exclusion criteria: The existing known factors such as family history, chromosome, anatomy, endocrine, blood group incompatibility, infection and autoantibody were excluded.

Design outcomes

Primary

MeasureTime frame
T cell;

Countries

China

Contacts

Public ContactZheng Jiayong

Wenzhou People's Hospital

wryfcksys@163.com+86 13958955660

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026